To decipher the USP22 functions in generating and/or maintaining breast cancer cell stemness, we generated USP22 targeted deletion in mouse 4T1 and human breast cancer-derived L2G+ TN1 cells by a CRISPR-Cas9 approach. The gene discussed is USP22; the disease is breast carcinoma.